Cargando…

Survival benefit of radiotherapy in metastatic esophageal cancer: a population-based study

BACKGROUND: Population-based estimates of survival benefits of radiotherapy on metastatic esophageal cancer (EC) are lacking. The aim of this study was to analyze survival benefits of radiotherapy in patients with metastatic EC at the time of cancer diagnosis. METHODS: Patients with metastatic EC we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiangpan, Zhang, Huibo, Jia, Xuemei, Xu, Liming, Liu, Huali, Chen, Liang, Song, Qibin, Hui, Zhouguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797641/ https://www.ncbi.nlm.nih.gov/pubmed/35116850 http://dx.doi.org/10.21037/tcr.2019.06.15

Ejemplares similares

Nomogram predicts survival benefit for non- metastatic esophageal cancer patients who underwent preoperative radiotherapy
por: Xie, Kenan, et al.
Publicado: (2018)

The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma
por: Li, Xiangpan, et al.
Publicado: (2022)

Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
por: Yao, Yi, et al.
Publicado: (2019)

Primary tumor resection benefited the survival of patients with distant metastatic gastric cancer
por: Gao, Yan, et al.
Publicado: (2021)

Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older
por: Huang, Shan, et al.
Publicado: (2017)

A nomogram for predicting overall survival in patients with low‐grade endometrial stromal sarcoma: A population‐based analysis
por: Wu, Jie, et al.
Publicado: (2020)

Effect of radiotherapy interruption due to COVID-19 outbreak
por: Yu, Dongdong, et al.
Publicado: (2021)

Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy
por: Gao, Lin-Rui, et al.
Publicado: (2022)

Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Positive Patient With Refractory Metastatic Thyroid Hürthle Cell Carcinoma: A Case Report and Literature Review
por: He, Haihua, et al.
Publicado: (2021)

Status of radiotherapy staff during the coronavirus disease 2019 (COVID‐19) epidemic in China
por: Wang, Hui, et al.
Publicado: (2021)

Surgery Combined with Radiotherapy Improved Survival in Metastatic Esophageal Cancer in a Surveillance Epidemiology and End Results Population-based Study
por: Wu, San-Gang, et al.
Publicado: (2016)

Preoperative Radiotherapy Is Associated With Significant Survival Benefits for Patients With Gastric Signet Ring Cell Carcinoma: A SEER-Based Approach
por: Gong, Hongyun, et al.
Publicado: (2020)

Adjuvant radiotherapy may have significant survival benefits for gastric cancer patients with 1-29 lymph nodes retrieved
por: Wu, Siyi, et al.
Publicado: (2020)

Multivariate gene expression‐based survival predictor model in esophageal adenocarcinoma
por: Zhao, Maoyuan, et al.
Publicado: (2020)

Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2015)

Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy
por: Chang, Xiao, et al.
Publicado: (2021)

The Effect of the Appropriate Timing of Radiotherapy on Survival Benefit in Patients with Metastatic Esophageal Cancer Who Have Undergone Resection of Primary Site: A SEER Database Analysis
por: Qiu, Bingzhe, et al.
Publicado: (2022)

No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis
por: Zheng, Si-Yue, et al.
Publicado: (2022)

High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis
por: Sun, Xin, et al.
Publicado: (2020)

Radiotherapy for esophageal carcinoma: dose, response and survival
por: Luo, Yijun, et al.
Publicado: (2017)

Long-Term Clinical Outcomes and Safety Analysis of Superficial Esophageal Cancer Patients Treated with Definitive or Adjuvant Radiotherapy
por: Lyu, Bo, et al.
Publicado: (2022)

Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma
por: Song, Yaqi, et al.
Publicado: (2016)

Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy
por: Chen, Chu-Ying, et al.
Publicado: (2022)

Nomogram predicts survival benefit from preoperative radiotherapy for non-metastatic breast cancer: A SEER-based study
por: Liu, Jianjun, et al.
Publicado: (2017)

Effect of radiotherapy interruption on nasopharyngeal cancer
por: Zhao, Fangrui, et al.
Publicado: (2023)

Additional Radiotherapy With or Without Chemotherapy Following Endoscopic Resection for Stage I Esophageal Carcinoma: A Pilot Study
por: Yang, Xu, et al.
Publicado: (2021)

Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer
por: Hingorani, Mohan, et al.
Publicado: (2015)

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019)

Palliative Gastrectomy and Survival in Patients With Metastatic Gastric Cancer: A Propensity Score–Matched Analysis of a Large Population-Based Study
por: Li, Qin, et al.
Publicado: (2019)

Investigation of female survival benefit in metastatic melanoma
por: Richardson, B, et al.
Publicado: (1999)

Impact of the number of resected lymph nodes on survival after preoperative radiotherapy for esophageal cancer
por: Wu, San-Gang, et al.
Publicado: (2016)

Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis
por: Wang, Xia, et al.
Publicado: (2023)

The survival impact of radiotherapy on synchronous metastatic rectal cancer: metastatic site can serve for radiotherapy-decision
por: Zhou, Yuan, et al.
Publicado: (2022)

The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
por: Xu, Biaoxiang, et al.
Publicado: (2022)

BACH1: A Potential Predictor of Survival in Early-Stage Lung Adenocarcinoma
por: Zhou, Jin, et al.
Publicado: (2022)

Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Lei, Tianyu, et al.
Publicado: (2021)

Survival and Symptom Relief after Palliative Radiotherapy for Esophageal Cancer
por: Welsch, Julia, et al.
Publicado: (2016)

Survival Impact of Delaying Postoperative Radiotherapy in Patients with Esophageal Cancer
por: Wang, Yuanyuan, et al.
Publicado: (2018)

Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial
por: Liang, Jun, et al.
Publicado: (2013)

Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
por: Yuan, Meng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tiofcuv7nfrq370lss62670ats